Avanos Medical, Inc.
Avanos Medical, Inc. (AVNS) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001606498 · AVNS · NYSE · as of Jun 8, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001606498 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Avanos Medical, Inc. (NYSE: AVNS) has submitted 703 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2014. As a Healthcare sector company with CIK 0001606498, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Avanos Medical, Inc.'s most comprehensive regulatory disclosure. The most recent Avanos Medical, Inc. 10-K was filed on 2026-02-24 for fiscal year ending 2026. Historical AVNS 10-K annual reports are available from 2014 through 2026.
Investors researching Avanos Medical, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
AVNS SEC Filings · 8 questionsAvanos Medical, Inc. (AVNS) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 703 filings and access original documents at no cost. Avanos Medical, Inc.'s CIK is 0001606498.